-
Lazio pull clear at Serie A summit
-
Almgren makes triumphant marathon debut in New York
-
Trump's Republicans scramble to stop Democratic midterms wave
-
Chinese state TV fails to air Real Madrid match after Mbappe row
-
Imperious Alcaraz crushes dogged De Minaur in Vienna final
-
France launches 'attempted murder' probe after petrol bomb attacks on security forces
-
Five things to know about Poland's constitutional crisis
-
Bayern's Saibari sidelined after ankle surgery
-
Sailors blessed with good weather as Route du Rhum gets underway
-
France launches 'attempted murder' probe after petrol bomb attack on security forces
-
Yamaha pulls out of Qatar MotoGP over 'Middle East situation'
-
Tens of thousands protest in India's capital against voter roll revision
-
Longest truce of Ukraine war, in Kherson region, set to end
-
Irish European athletics champion Ciara Mageean dies aged 34
-
Luckless Lawson demoted to back of grid for Mexico City Grand Prix
-
Seifert blasts 93 as New Zealand win fifth India T20
-
Marquez wins in Malaysia to close in on MotoGP world title
-
Portuguese police clash with housing protesters, arrest 13
-
Thousands protest in India's capital against voter roll revision
-
Marquez wins in Malaysia to stand on brink of MotoGP world title
-
Marquez wins Malaysian MotoGP to move to brink of world title
-
Binance says resuming withdrawals after major hack
-
Shnaider beats Fernandez to win Tokyo title
-
Divided Bulgaria votes in tense presidential runoff
-
Winds of change: Laos looks up for renewables push
-
Trump says US looking 'closely' at report Nvidia CEO target of China spy plot
-
Sri Lanka's war widows and the long search for the missing
-
Maxey scores 38 to lead Sixers 'fighters' to another comeback win
-
'Air-con nation' Singapore eyes alternatives to cool down
-
Valkyries defeat Dream to capture first WNBA crown
-
US judge dismisses Trump lawsuit against Wall Street Journal over Epstein letter
-
'Seen and heard': Uruguay neighborhood places hopes in pope
-
Slave or not? US gallery shows early photos of African Americans
-
Spewing US election falsehoods, AI chatbots face scrutiny
-
France's Aymoz wins Skate Canada men's crown
-
EU's new levy on parcels kicks in
-
Pope Leo readies for 'intense' South America homecoming
-
Ocon denies reports of altercation after being dumped by Haas
-
Antonelli admits to feeling tense of eve of potential F1 title decider
-
Hamilton says love of racing keeps him young
-
FBI says North Korea behind $6 billion crypto theft from Binance
-
'Disgraceful' Australia face reckoning after South Africa humbling
-
Behind The Bottle: SoCal Cocktail & Spirits Fest 2026 Now Streaming on Spotify
-
'Canelo' Alvarez wins back WBC title from Mbilli in Riyadh
-
Sovereignty wins Breeders' Cup Classic, Benvenuto Cellini triumphs in Turf for O'Brien
-
'Canelo' Alvarez wins back WBC title from Mbilli
-
Hamilton takes record 105th pole and first for Ferrari, as Antonelli lurks
-
Sovereignty wins Breeders' Cup Classic
-
German rioters loot shops as 'Gen Z' demos turn ugly
-
Hamilton grabs pole position for Mexican Grand Prix
Modular Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
SAN DIEGO, CA / ACCESS Newswire / April 16, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery, today announced that it has received a letter from the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it has regained compliance with the Nasdaq Capital Market's minimum bid price continued listing requirement. The letter noted that, as of April 14, 2026, the Company evidenced a closing bid price of its common stock in excess of the $1.00 minimum requirement for the last 10 consecutive trading days. Accordingly, the Company has regained compliance with Nasdaq Marketplace Rule 5550(a)(2) and Nasdaq considers the matter closed.
About Modular Medical
Modular Medical, Inc. (Nasdaq:MODD) is a development-stage medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the Company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Its mission is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers" and providing "diabetes care for the rest of us."
Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding Modular Medical, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at https://modular-medical.com.
CONTACT:
Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741
[email protected]
SOURCE: Modular Medical, Inc.
View the original press release on ACCESS Newswire
B.Finley--AMWN